Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1986 Nov;54(5):755–760. doi: 10.1038/bjc.1986.237

Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck.

A Thyss, M Schneider, J Santini, C Caldani, J Vallicioni, P Chauvel, F Demard
PMCID: PMC2001551  PMID: 3801272

Abstract

One hundred and eight patients with squamous cell carcinoma of the upper aerodigestive tract (UADT) (T3, T4, NO-N3; 17% stage II, 54% stage III, 27% stage IV) were given three courses of chemotherapy before any local treatment. The regimen consisted of cis-platinum 100 mg m-2 on day 1 and 5-fluorouracil 1000 mg m-2 on days 2-6; drugs were administered by continuous infusion. The toxicity of this protocol was acceptable, as 82% of the patients were able to receive the initially scheduled drug dose. The overall response rate of 86.5% included a 35% rate of complete lesion regression. The effect of this regimen on primary tumours was especially remarkable--87.5% responses, including 47.5% complete responses. Results for lymph node metastases were not as good--66% responses, including 33% complete responses. The best results were obtained for tumours of the oropharynx and hypopharynx; oral cavity lesions were the most refractory. For those patients who were subsequently operated on, histological examination of the surgical specimen either confirmed sterilization or demonstrated the persistence of small disease foci. After local treatment, which consisted of radiotherapy alone for 69% of patients, the lesion control rate was 80%. At 18 months follow-up, the survival rate for patients who achieved a complete response with chemotherapy was significantly better than that for patients with a response of less than 50%.

Full text

PDF
755

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Al-Sarraf M., Amer M. H., Vaishampayan G., Loh J., Weaver A. A multidisciplinary therapeutic approach for advanced previously untreated epidermoid cancer of the head and neck: preliminary report. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1421–1423. doi: 10.1016/0360-3016(79)90682-5. [DOI] [PubMed] [Google Scholar]
  2. Bertino J. R., Boston B., Capizzi R. L. The role of chemotherapy in the management of cancer of the head and neck: a review. Cancer. 1975 Aug;36(2):752–758. doi: 10.1002/1097-0142(197508)36:2+<752::aid-cncr2820360820>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  3. Brown A. W., Jr, Blom J., Butler W. M., Garcia-Guerrero G., Richardson M. F., Henderson R. L. Combination chemotherapy with vinblastine, bleomycin, and cis-diamminedichloroplatinum (II) in squamous cell carcinoma of the head and neck. Cancer. 1980 Jun 1;45(11):2830–2835. doi: 10.1002/1097-0142(19800601)45:11<2830::aid-cncr2820451119>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  4. Carter S. K. The chemotherapy of head and neck cancer. Semin Oncol. 1977 Dec;4(4):413–424. [PubMed] [Google Scholar]
  5. Demard F., Schneider M., Vallicioni J., Chauvel P., Lesbats G. Chimiothérapie première associant vincristine, bléomycine, méthotrexate et cis-platine par voie systémique ou intra-artérielle dans les cancers des voies aéro-digestives supérieures. Ann Otolaryngol Chir Cervicofac. 1983;100(8):567–575. [PubMed] [Google Scholar]
  6. Demard F., Schneider M., Vallicioni J., Santini J., Chauvel P. Chimothérapie intra-artérielle des tumeurs ORL. 10 ans d'expérience au Centre Antoine-Lacassagne. Ann Otolaryngol Chir Cervicofac. 1985;102(5):285–291. [PubMed] [Google Scholar]
  7. Ervin T. J., Kirkwood J., Weichselbaum R. R., Miller D., Pitman S. W., Frei E., 3rd Improved survival for patients with advanced carcinoma of the head and neck treated with methotrexate-leucovorin prior to definitive radiotherapy or surgery. Laryngoscope. 1981 Jul;91(7):1181–1190. doi: 10.1288/00005537-198107000-00018. [DOI] [PubMed] [Google Scholar]
  8. Ervin T. J., Weichselbaum R. R., Fabian R. L., Miller D., Norris C. M., Jr, Posner M. R., Rose C., Lockhart P., Tuttle S. A., MacIntyre J. M. Advanced squamous carcinoma of the head and neck. A preliminary report of neoadjuvant chemotherapy with cisplatin, bleomycin, and methotrexate. Arch Otolaryngol. 1984 Apr;110(4):241–245. doi: 10.1001/archotol.1984.00800300033007. [DOI] [PubMed] [Google Scholar]
  9. Fazekas J. T., Sommer C., Kramer S. Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx. Int J Radiat Oncol Biol Phys. 1980 May;6(5):533–541. doi: 10.1016/0360-3016(80)90379-x. [DOI] [PubMed] [Google Scholar]
  10. Glick J. H., Marcial V., Richter M., Velez-Garcia E. The adjuvant treatment of inoperable stage III and IV epidermoid carcinoma of the head and neck with platinum and bleomycin infusions prior to definitive radiotherapy: an RTOG pilot study. Cancer. 1980 Nov 1;46(9):1919–1924. doi: 10.1002/1097-0142(19801101)46:9<1919::aid-cncr2820460905>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  11. Jacobs C., Bertino J. R., Goffinet D. R., Fee W. E., Goode R. L. 24-hour infusion of cis-platinum in head and neck cancers. Cancer. 1978 Nov;42(5):2135–2140. doi: 10.1002/1097-0142(197811)42:5<2135::aid-cncr2820420508>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  12. Kish J., Drelichman A., Jacobs J., Hoschner J., Kinzie J., Loh J., Weaver A., Al-Sarraf M. Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of the head and neck. Cancer Treat Rep. 1982 Mar;66(3):471–474. [PubMed] [Google Scholar]
  13. Lacau St Guily J., Brasnu D., Bassot V., Chevalier H., Jacquillat C., Laccourreye H. Chimiothérapie d'induction des cancers des voies aéro-digestives supérieures. Analyse de la réponse tumorale chez 176 malades. Presse Med. 1985 Jun 15;14(24):1313–1316. [PubMed] [Google Scholar]
  14. Micheau C., Richard J. Actions tissulaires de la chimiothérapie intra-artérielle (C.I.A.) dans les cancere pelvi-linguaux et leurs métastases ganglionnaires. (A propos de 47 cas) Ann Otolaryngol Chir Cervicofac. 1975 Sep;92(9):499–508. [PubMed] [Google Scholar]
  15. Probert J. C., Thompson R. W., Bagshaw M. A. Patterns of spread of distant metastases in head and neck cancer. Cancer. 1974 Jan;33(1):127–133. doi: 10.1002/1097-0142(197401)33:1<127::aid-cncr2820330119>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  16. Randolph V. L., Vallejo A., Spiro R. H., Shah J., Strong E. W., Huvos A. G., Wittes R. E. Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy. Cancer. 1978 Feb;41(2):460–467. doi: 10.1002/1097-0142(197802)41:2<460::aid-cncr2820410213>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  17. Rooney M., Kish J., Jacobs J., Kinzie J., Weaver A., Crissman J., Al-Sarraf M. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer. 1985 Mar 1;55(5):1123–1128. doi: 10.1002/1097-0142(19850301)55:5<1123::aid-cncr2820550530>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  18. Schabel F. M., Jr, Trader M. W., Laster W. R., Jr, Corbett T. H., Griswold D. P., Jr cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1459–1473. [PubMed] [Google Scholar]
  19. Slotman G. J., Mohit T., Raina S., Swaminathan A. P., Ohanian M., Rush B. F., Jr The incidence of metastases after multimodal therapy for cancer of the head and neck. Cancer. 1984 Nov 1;54(9):2009–2014. doi: 10.1002/1097-0142(19841101)54:9<2009::aid-cncr2820540938>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES